The International Union against Cancer has been particularly interested in the clinical classification of all malignant tumours since 1953. For many years, various methods of classification have been proposed. This multiplicity is an indication that no one method has given satisfaction to the majority of people who are interested in this subject and it is for this reason that each method has been repeatedly changed. What is essential in any clinical classification, more perhaps than the actual details, is the fact that it can be used and accepted by the largest number of people, so that it will fulfil its primary functionto be used as a common language to allow exchanges of information, discussion and the making of comparisons between different methods of treatment.
The qualities required for a system of classification are that it should be simple to use, and that it should be precise. If these conditions are not met, there is little chance that such a system will be used on an international basis.
The custom of dividing cancer patients into groups which one considers under the word 'stage' is based on the idea that the cure rate is higher in a patient where the disease is localized, than in a patient where the tumour has spread beyond the organ of origin. This has established a certain confusion. The use of the word 'stage' has suggested incorrectly that some tumours are early and others are late. It implies that one has precise information on the time taken for the development of the tumour. In fact this is not the case, as one can only recognize that this staging is a degree of tumour extension. One may assume that when a tumour is small it is an early one, and that where a tumour has extended into adjoining tissue, it is late. However, this assumption is far from justified. It is this confusion that often makes comparison between different methods of classification of tumours extremely difficult.
A clinical classification of a tumour must fulfil certain functions:
(1) It must help the clinician to decide on a programme of treatment which is based on the assessment of the clinical condition of the patient. One can subsequently alter the plan of treatment depending on changing circumstances, especially if there has been surgical intervention. It should be essential, however, that in the majority of cases the first planned treatment should be decided on the basis of a clinical examination, and it is therefore important that it should be used in every case, if one has to understand and to compare the results at various clinics.
(2) It should assist in the evaluation of the therapeutic results.
(3) It should facilitate the exchange of information between different institutes specializing in the treatment of cancer.
(4) It should allow the collection of information which has a bearing on the natural history of the tumour and it should help in understanding the biological behaviour of the tumour.
The idea of a clinical classification is of particular importance when many tumours are being treated by other methods as well as surgery. It is essential that the surgeon does not have an advantage over the immunotherapist, the chemotherapist or radiotherapist in analysing his cases, by the introduction of a factor which can be discovered only on laparotomy. If a surgeon is allowed to modify the analysis of his treatment to exclude all cases where adverse factors are discovered by laparotomy, it will never be possible to compare two series of cases or to compare the results of two different techniques.
The object of a classification then is that it should be accepted by the greatest number of people, it should allow the patients to be grouped clinically according to the extension of the disease, and it should allow the comparison of methods of treatment, while at the same time assisting in giving an accurate prognosis.
Principle ofa TNM System ofClassification The TNM system is intended to be a collection of terms which can be used with precision and which can subsequently be reassembled, depending on later information, in order to decide which factors are relevant and which are not. It is essential that these terms are employed accurately, without misuse. It must be stressed that the TNM is a classification with a view to deciding subsequently some method of staging, but it is not a staging system into which many factors may be incorporated which are irrelevant to each other.
The advantage of the TNM which distinguishes it from all other systems is that it is based on three main processes: a descriptive analysis of the local spread of the tumour; a description, if this can be achieved, ofthe clinical state of the regional nodes, provided these nodes are accessible to clinical examination; a statement about the presence or absence of distant metastases beyond the regional nodes.
When we examine a patient we consider different elements ofthe clinical picture, we record and combine them. Our brains function like an electronic machine which finally produces an impression that is an indication for the treatment.
The system TNM is a form of clinical shorthand which aims to make this impression more objective. Facts must be recorded, transcribed, arranged in groups and subsequently analysed. This approach is now better understood and the more interested one gets in the system TNM in producing analyses, the less one has to rely on reclassifying patients at a subsequent date. In the TNM system it is of major importance to describe but not to attempt to interpret. There are certain rules, however, that are essential for the accurate use of the system: every case must be included in a series published; every case must be classified according to the clinical findings; every case must be investigated adequately.
Because urology is perhaps one of the most exact of the surgical specialties the system is particularly suitable for the classification of tumours of the urinary tract. The TNM system originally described for the bladder in 1962 was modified in 1968 to include prostate, kidney and testis, and has been modified again this year to remove certain anomalies. In particular, the definitions of the N classification have been standardized so that these are the same for all sites. The M definition has also been extended and standardized so that again there is no confusion. The term G has been introduced in order to define the grade of malignancy of a tumour rather than have the grade reflected in any of the other symbols. It is essential to remember that grade may well be a pathological opinion rather than a fact, and it is possible that one pathologist may have a different opinion from another or even change his opinion over a period of time.
The urological sites were the first where it was recognized that many cases treated by surgery would allow a pathological classification as well. The use of the term P is restricted to those cases that can be classified on the basis of an operative specimen. For example, where a bladder is treated by surgery a clinical classification may be available before surgery and a pathological classification after. This allows a method of checking for the accuracy of the clinical classification or for evaluating the effects of preoperative therapy. In the kidney and prostate, the P classification may also be used, possibly to greater advantage. In the testicle where very frequently the testis itself has been removed, the P classification may be the only one available to indicate the extent of spread of the tumour.
Prostate
There have been certain recommendations put forward for the classification of prostatic tumours.
In every case there must be histological or cytological confirmation of the diagnosis, either from the primary growth or from the metastases. In the clinical classification of carcinoma of the prostate one must make allowance for the accidental discovery of a carcinomatous focus in an operative specimen. The use of the symbol TX has been suggested to indicate a tumour where there was no clinical suspicion of malignancy. The mere size of a carcinoma may also be of value because it has been shown that the larger the primary tumour, the higher the incidence of lymphatic node metastases within the pelvis. Allowance for the size has also been made in the clinical classification of tumours.
The involvement of the bladder neck and the distortion of the urethra are also taken as evidence of extensive spread, but these factors put the patient in a different category to those where there is a massive involvement of the whole bladder base.
Bladder
Considerable controversy still exists concerning non-invasive tumours. However, in principle, the in-situ carcinoma, a non-papillary, non-invasive intramucosal lesion, is recognized as being quite a different type of tumour to a papilloma or a non-invasive papillary carcinoma. The original definitions as proposed for the bladder are in general agreed, but in addition the presence or absence of lymphatic invasion is ofconsiderable prognostic importance, as well as the histological grade of the tumour. Both of these have been included in the new classification, i.e. lymphatics: capital L and G grade as defined by the WHO panel of pathologists.
Kidney
In the kidney the clinical classification is difficult, but an attempt has been made to define it as regards palpability. The pathological classification for kidneys, however, is more exact. Several observers have suggested different methods including up to nine different categories for the local spread of the tumour, three for lymphatic nodes and three for the presence or absence of vein involvement. It is felt, however, that it is simpler to divide the P classification of kidney tumours into P 1 where there is involvement of the renal parenchyma only, P 2 where the tumour is involving the capsule, P 3 where it has broken through and is involving the perinephric fat, and P 4 where the tumour is involving other organs. It is suggested that the veins should be classified as vein-free or vein-involved and that in addition the grade of the tumour should be incorporated.
Testis
Here it is the histological type of tumour that is of most importance. The treatment is, however, similar for all types. The clinical estimation of the extent of spread is very rarely possible, partly because it is often difficult to distinguish the extent of the tumour, and partly because the tumour has frequently been excised. The only important factor in the extent of spread of the tumour is where previous surgery has resulted in dissemination of the tumour into the scrotal skin. The presence or absence of lymphatic nodes is of vital importance. Here it can be decided by lympho-graphy (N 0 or N 1) and these can then be confirmed by subsequent retroperitoneal node dissection, when this is practised, so that a negative or a positive sign can be added. Lymphatic nodes beyond the diaphragm are by definition metastases but these are of much more favourable import than metastases elsewhere. Metastases from any testicular tumour in the liver, for example, are virtually fatal. Thus the various aspects of testis tumours can be grouped and analysed separately, rather than by arbitrarily attempting to put each case into a stage which will depend on a variety of factors.
Future ofthe TNM Classification
These recommendations are at present being considered by an international committee, but it is suggested that if the TNM system is understood and if definitions can be adhered to, it will be possible to compare the results of treatment and the behaviour of tumours on an international basis, and also by various disciplines using a variety of methods of treatment.
The collection of all these facts under different headings according to preconceived ideas although valuable today may not be so in the future. It is customary nowadays to consider that patients with metastatic disease have a poor prognosis, but it is possible that tomorrow the metastases may be treated more easily, perhaps more so than the primary tumour, if either chemotherapy or immunotherapy produces an effective treatment on small distant tumours which is less effective on a large primary tumour. If this day arrives the order of severity into which we have classified our cases, i.e. stages 1, 2, 3 and 4 may have to be modified. Stage 4 may become one of the least severe stages and it is because of this that one must make arrangements for the possible regrouping of the clinical facts under each individual heading.
